Andrzej Kulczycki1, Haiyan Qu2, Richard Shewchuk2. 1. Department of Health Care Organization and Policy, University of Alabama at Birmingham, Birmingham, Alabama. Electronic address: andrzej@uab.edu. 2. Department of Health Services Administration, School of Health Professions, University of Alabama at Birmingham, Birmingham, Alabama.
Abstract
BACKGROUND: Inadequate physician adherence to guidelines has received scant attention as a possible cause of suboptimal human papillomavirus (HPV) vaccination rates. We assessed the extent to which primary care physicians (PCPs) adhere to clinical guidelines and their reported intentions to prescribe HPV vaccine to females in the targeted age group, and how this is influenced by perceptions of guideline clarity and other factors. METHODS: We surveyed 301 PCPs to explore their sociodemographic and practice-related characteristics, beliefs, professional norms, and perceived barriers to administer HPV vaccine. Logistic regression predicted the likelihood to prescribe HPV vaccine to 11- and 12-year-old girls on an array of variables hypothesized to influence physicians' recommendations. RESULTS: Only 67% of PCPs reported being likely to prescribe HPV vaccine to 11- and 12-year-old patients. PCPs were more likely to prescribe vaccine to 11- and 12-year-old girls if they believed HPV vaccine guidelines were clear (odds ratio [OR], 1.85; 95% CI, 1.03-3.35), agreed with a mandate requirement (OR, 2.39; 95% CI, 1.01-5.61), felt comfortable discussing HPV vaccination with early adolescent girls (OR, 5.10; 95% CI, 2.75-9.45), and had at least 25% of their patients using public assistance to pay for their clinic visits (OR, 3.82; 95% CI, 1.91-7.34). Practice specialty (family physicians or pediatricians) and region were not significant predictors. CONCLUSIONS: PCPs exhibit moderate levels of adherence to professional guidelines regarding HPV vaccination. Potential public health benefits will not be realized without stronger efforts to improve the rates at which PCPs administer the vaccine, particularly to 11- and 12-year-olds for whom it is preferentially recommended.
BACKGROUND: Inadequate physician adherence to guidelines has received scant attention as a possible cause of suboptimal human papillomavirus (HPV) vaccination rates. We assessed the extent to which primary care physicians (PCPs) adhere to clinical guidelines and their reported intentions to prescribe HPV vaccine to females in the targeted age group, and how this is influenced by perceptions of guideline clarity and other factors. METHODS: We surveyed 301 PCPs to explore their sociodemographic and practice-related characteristics, beliefs, professional norms, and perceived barriers to administer HPV vaccine. Logistic regression predicted the likelihood to prescribe HPV vaccine to 11- and 12-year-old girls on an array of variables hypothesized to influence physicians' recommendations. RESULTS: Only 67% of PCPs reported being likely to prescribe HPV vaccine to 11- and 12-year-old patients. PCPs were more likely to prescribe vaccine to 11- and 12-year-old girls if they believed HPV vaccine guidelines were clear (odds ratio [OR], 1.85; 95% CI, 1.03-3.35), agreed with a mandate requirement (OR, 2.39; 95% CI, 1.01-5.61), felt comfortable discussing HPV vaccination with early adolescent girls (OR, 5.10; 95% CI, 2.75-9.45), and had at least 25% of their patients using public assistance to pay for their clinic visits (OR, 3.82; 95% CI, 1.91-7.34). Practice specialty (family physicians or pediatricians) and region were not significant predictors. CONCLUSIONS: PCPs exhibit moderate levels of adherence to professional guidelines regarding HPV vaccination. Potential public health benefits will not be realized without stronger efforts to improve the rates at which PCPs administer the vaccine, particularly to 11- and 12-year-olds for whom it is preferentially recommended.
Authors: Matthew F Daley; Lori A Crane; Lauri E Markowitz; Sandra R Black; Brenda L Beaty; Jennifer Barrow; Christine Babbel; Sami L Gottlieb; Nicole Liddon; Shannon Stokley; L Miriam Dickinson; Allison Kempe Journal: Pediatrics Date: 2010-08-02 Impact factor: 7.124
Authors: Jessica A Kahn; H Paul Cooper; Susan T Vadaparampil; Barbara C Pence; Armin D Weinberg; Salvatore J LoCoco; Susan L Rosenthal Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-08 Impact factor: 4.254
Authors: Susan Hariri; Elizabeth R Unger; Maya Sternberg; Eileen F Dunne; David Swan; Sonya Patel; Lauri E Markowitz Journal: J Infect Dis Date: 2011-08-15 Impact factor: 5.226
Authors: Lea E Widdice; David I Bernstein; Anthony C Leonard; Keith A Marsolo; Jessica A Kahn Journal: Pediatrics Date: 2010-12-13 Impact factor: 7.124
Authors: Emiko Petrosky; Joseph A Bocchini; Susan Hariri; Harrell Chesson; C Robinette Curtis; Mona Saraiya; Elizabeth R Unger; Lauri E Markowitz Journal: MMWR Morb Mortal Wkly Rep Date: 2015-03-27 Impact factor: 17.586
Authors: Suellen Hopfer; Margaret E Wright; Harry Pellman; Richard Wasserman; Alexander G Fiks Journal: Hum Vaccin Immunother Date: 2019-01-30 Impact factor: 3.452
Authors: Cynthia A Bonville; Joseph B Domachowske; Donald A Cibula; Manika Suryadevara Journal: Hum Vaccin Immunother Date: 2017-10-13 Impact factor: 3.452
Authors: Albert J Farias; Lara S Savas; Maria E Fernandez; Sharon P Coan; Ross Shegog; C Mary Healy; Erica Lipizzi; Sally W Vernon Journal: Prev Med Date: 2017-08-20 Impact factor: 4.018
Authors: Melissa B Gilkey; Mo Zhou; Annie-Laurie McRee; Melanie L Kornides; John F P Bridges Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-06-14 Impact factor: 4.254
Authors: Abigail M Schnaith; Erica M Evans; Caleb Vogt; Andrea M Tinsay; Thomas E Schmidt; Katelyn M Tessier; Britt K Erickson Journal: Vaccine Date: 2018-05-31 Impact factor: 3.641